Breaking News

Molecular Profiles Appoints Head of U.S. Sales

May 13, 2014

Aims to expand presence in North American market

Charles D. Maher has been appointed head of U.S. sales at Molecular Profiles to expand the company’s client base in the U.S. for its pharmaceutical development services. He will focus on technologies with advanced characterization, formulation development and manufacturing.The company also recently invested in GMP hot melt extrusion (HME) technology for processing of difficult-to-progress molecules.   
Mr. Maher has extensive senior commercial experience in the global contract services market. Most recently he served as vice president of Business Global Development, U.S. and Europe for an international pharmaceutical R&D services company. 
Dr. Nikin Patel, chief executive officer at Molecular Profiles, said, “Over the years, we have built a solid reputation in Europe for applying a science driven approach to our clients’ development challenges in a cost-effective manner that delivers value by accelerating development. We are now striding toward executing our strategy to replicate this success in the U.S.
“I am delighted to welcome Charles to the company. His extensive knowledge of the market, experience and strong industry contacts should benefit our efforts to capitalize on our state-of-the-art facility, manufacturing capabilities and growing suite of enabling technologies among pharmaceutical and biotech companies.”
  • U.S. Pharma Market Trends

    Kristin Brooks, Contract Pharma||April 8, 2016
    CPhI Report sees return of generic and API manufacturing to U.S. market

  • DCAT Week ’16 Session Highlights

    Kristin Brooks, Contract Pharma||March 24, 2016
    API and Dose CMO Market Trends and Supply Strategies

  • Talking Trends with Aesica

    Talking Trends with Aesica

    Tim Wright, editor||February 26, 2016
    Managing director Ian Muir fills us in on the latest at the CDMO